Viewing Study NCT00236756


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2025-12-25 @ 9:04 PM
Study NCT ID: NCT00236756
Status: COMPLETED
Last Update Posted: 2011-06-03
First Post: 2005-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1993-08
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2001-02
Completion Date Type: ACTUAL
First Submit Date: 2005-10-07
First Submit QC Date: None
Study First Post Date: 2005-10-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-06-02
Last Update Post Date: 2011-06-03
Last Update Post Date Type: ESTIMATED